Clinical Trials Browser

Phase 2 × Plasmacytoma × daratumumab × Clear all

NCT01946477 2025-06-06

POM MM 014

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasmacytoma

NCT04065308 2019-08-22

Dara_DCEP

Phase 2 Unknown

Plasmacytoma